disAMR Acquires AMR Insights to Combat Antimicrobial Resistance Globally
On February 24, 2026, disAMR, a newly established organization founded by prominent figures in the life sciences sector, including Mark Bamforth OBE and Dr. Richard Snyder, announced their acquisition of AMR Insights. This platform, which originated in Amsterdam in 2016, has been pivotal in addressing antimicrobial resistance (AMR) by creating a global network for communication and information sharing. The newly formed disAMR is dedicated to providing innovative solutions and educational resources to combat the escalating threat of AMR, which the World Health Organization (WHO) has identified as one of the most pressing public health challenges. The gravity of the AMR crisis cannot be understated; in 2019 alone, bacterial resistance directly caused 1.27 million deaths, with projections estimating this could rise to nearly 2 million annually by 2050 if not addressed. With funding and investment into antibiotic innovation at a critical juncture, disAMR aims to be the central hub for promoting awareness, influencing policy, and connecting crucial shareholders across various sectors.
Mark Bamforth, now the Chief Executive Officer of disAMR, expressed the pressing need for a robust response to AMR, stating, "Despite the innovation emerging from many parts of the world, financial support remains insufficient due to market failures. This organization aims to foster awareness of AMR as a significant global health crisis and to leverage innovation through funding and engaged community actions."
The collaboration with AMR Insights marks a promising phase in disAMR's journey, as it seeks to expand the existing platform while introducing a new multichannel digital resource. Dr. Richard Snyder, Chief Scientific Officer, emphasized the goal to unify fragmented efforts within the AMR sphere, thereby providing visibility and renewed motivation to stakeholders involved in combating this urgent problem. "Through disAMR, we aspire to establish a cohesive front against AMR, catalyzing collaboration and actionable strategies that can alter the current dire landscape," he remarked.
The meaningful partnership extends further with That's Nice LLC, an established agency in life sciences branding and communications. Their expertise is poised to enhance disAMR’s visibility and engage stakeholders efficiently across the biotechnology and pharmaceutical realms.
Dr. Maarten van Dongen, founder of AMR Insights, highlighted his confidence in disAMR's leadership, which he believes will advance the mission of AMR Insights to greater heights. The aim is clear: to craft a comprehensive strategy that not only enhances the existing resources but also amplifies actions towards tackling antimicrobial resistance on a global scale.
disAMR is dedicated to fostering a collaborative network of innovators and stakeholders invested in solutions pertaining to AMR. They emphasize the importance of advocacy for policy reform and economic models that support long-term sustainability in antimicrobial development. Looking ahead, disAMR plans to launch a new digital platform in 2026 which promises to increase interaction and education among the various actors in AMR-related sectors.
In summary, disAMR's acquisition of AMR Insights is more than a mere corporate transaction; it represents a unified stance against one of modern medicine’s most significant threats. By harnessing resources, building partnerships, and promoting essential dialogue, disAMR is poised to encourage global action in the fight against antimicrobial resistance, reinforcing the urgent message that a collective effort is essential to combat this multifaceted crisis.
Mark Bamforth, now the Chief Executive Officer of disAMR, expressed the pressing need for a robust response to AMR, stating, "Despite the innovation emerging from many parts of the world, financial support remains insufficient due to market failures. This organization aims to foster awareness of AMR as a significant global health crisis and to leverage innovation through funding and engaged community actions."
The collaboration with AMR Insights marks a promising phase in disAMR's journey, as it seeks to expand the existing platform while introducing a new multichannel digital resource. Dr. Richard Snyder, Chief Scientific Officer, emphasized the goal to unify fragmented efforts within the AMR sphere, thereby providing visibility and renewed motivation to stakeholders involved in combating this urgent problem. "Through disAMR, we aspire to establish a cohesive front against AMR, catalyzing collaboration and actionable strategies that can alter the current dire landscape," he remarked.
The meaningful partnership extends further with That's Nice LLC, an established agency in life sciences branding and communications. Their expertise is poised to enhance disAMR’s visibility and engage stakeholders efficiently across the biotechnology and pharmaceutical realms.
Dr. Maarten van Dongen, founder of AMR Insights, highlighted his confidence in disAMR's leadership, which he believes will advance the mission of AMR Insights to greater heights. The aim is clear: to craft a comprehensive strategy that not only enhances the existing resources but also amplifies actions towards tackling antimicrobial resistance on a global scale.
disAMR is dedicated to fostering a collaborative network of innovators and stakeholders invested in solutions pertaining to AMR. They emphasize the importance of advocacy for policy reform and economic models that support long-term sustainability in antimicrobial development. Looking ahead, disAMR plans to launch a new digital platform in 2026 which promises to increase interaction and education among the various actors in AMR-related sectors.
In summary, disAMR's acquisition of AMR Insights is more than a mere corporate transaction; it represents a unified stance against one of modern medicine’s most significant threats. By harnessing resources, building partnerships, and promoting essential dialogue, disAMR is poised to encourage global action in the fight against antimicrobial resistance, reinforcing the urgent message that a collective effort is essential to combat this multifaceted crisis.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.